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 !  
"
	#  To investigate disease progression and treatment response in a murine model 
of chronic obstructive pulmonary disease (COPD) using a preclinical hyperpolarized 
129
Xe (HPXe) MRI strategy.  
	#  COPD phenotypes were induced in 32 mice by 10 weeks of exposure to 
cigarette smoke (CS) and lipopolysaccharide (LPS). The efficacy of ethyl pyruvate 
(EP), an anti6inflammatory drug, was investigated by administering EP to 16 of the 32 
mice after 6 weeks of CS and LPS exposure. HPXe MRI was performed to monitor 
changes in pulmonary function during disease progression and pharmacological 
therapy.   
		#  HPXe metrics of fractional ventilation and gas6exchange function were 
significantly reduced after 6 weeks of  CS and LPS exposure compared to 
sham6instilled mice administered with saline ( < 0.05). After this observation, EP 
administration was started in 16 of the 32 mice and continued for 4 weeks. EP was 
found to improve HPXe MRI metrics to a similar level as in sham6instilled mice ( < 
0.01). Histological  analysis showed significant alveolar  tissue destruction in the 
COPD group, but relatively normal alveolar structure in the EP and sham6instilled 
groups. 
!	#  This study demonstrates the potential efficacy of EP for COPD therapy, 
as assessed by a non6invasive, translatable 
1 29
Xe MRI procedure. 

	$# 200 
Keywords:  Hyperpolarized 
1 2 9
Xe MRI, lung functional assessment,  murine chronic 
obstructive pulmonary disease, treatment response, ethyl pyruvate 
 
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%&'(!&%
Chronic obstructive pulmonary disease (COPD), a heterogeneous lung disease 
characterized by both chronic airway inflammation and emphysematous alveolar tissue 
destruction, is predicted to be the third leading cause of death worldwide by 2020 (1).  
At present, pharmacological therapies for COPD have shown limited efficacy and thus 
the development of new therapeutic drugs is vital for improving patient outcomes (2).  
The use of appropriate animal models of  COPD that adequately induce the key 
symptoms of the disease is indispensable for therapy development, and rodent models 
are especially important. In particular, preclinical studies with mice are often 
appropriate because a wide range of well6characterized disease models is available 
(3,4). As smoking and repeated lung infections are the primary causes of COPD, 
several murine COPD models have been developed by exposing mice to cigarette 
smoke. Despite certain models showing good reproducibility for inducing the two 
main phenotypes of COPD mentioned above, the lack of applicable methods for 
assessment and diagnosis of these disease models remains a limiting factor for  
preclinical studies. Most previous studies have relied on plethysmography and/or  
histology to evaluate the applicability of murine COPD models, necessitating a 
tracheostomy and/or mouse death for each examination (5,6) and hence making it  
difficult to evaluate drug efficacy repeti tively and longitudinally. To help resolve this 
problem, non6invasive imaging techniques that allow the longitudinal assessment of 
disease progression and therapeutic efficacy of drugs in vivo are required.  
     MRI using hyperpolarized (HP) noble gases (
3
He and 
1 29
Xe) as contrast  agents 
offers an attractive means to visualize and quantitatively evaluate pulmonary 
functional parameters such as ventilation and gas6exchange (769) .  In a number of 
studies in small animals and humans, pathological changes of these fundamental 
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parameters have been investigated using HP gas MRI and quantitative measures of  
ventilation and gas6exchange dysfunction caused by COPD have been established 
(10,11). HP 
1 2 9
Xe (HPXe) is a versatile contrast agent to evaluate drug efficacy in the 
lungs because it allows not only imaging of  ventilation, but also the assessment of 
pulmonary gas6exchange, thanks to its solubility in pulmonary tissues and blood. To 
this end, we have developed a continuous6flow mode polarizer for  HPXe production 
and have established non6invasive MRI procedures under spontaneous respiration for 
the assessment of pulmonary function in mice (12,13). In this study, we apply our 
HPXe methodology to explore the feasibility of a new drug for COPD therapy. 
     Ethyl pyruvate (EP), an anti6inflammatory agent,  is a candidate for 
pharmacological therapy of COPD. In recent years, EP has been shown to demonstrate 
therapeutic efficacy in various animal models of lung diseases, such as acute lung 
injury (ALI) and pulmonary arterial hypertension (PAH) (15617). The therapeutic 
efficacy of EP is attributed to its ability to regulate high6mobility group box protein61 
(HMGB1) release from innate immune cells,  and to deactivate subsequent cytokine 
production that would further  stimulate inflammatory responses (18,19). HMGB1, 
which is an abundant chromatin protein, may play a crucial role in pharmacological  
therapy of COPD because it is known to not only trigger inflammatory responses but  
also, paradoxically, to activate cells involved in tissue repair (20624). HMGB1 
functions by binding with the receptor for advanced glycation end products (RAGE) 
and Toll6Like Receptors 2 and 4. In recent years, it  has been shown that HMGB1 can 
also initiate wound healing processes through binding with RAGE followed by 
activation of the extracellular signal6regulated kinase 1/2 (ERK1/2) signaling pathway 
(23). RAGE is expressed in pulmonary tissues with relatively high basal levels (22),  
and EP has been reported to activate the ERK1/2 signaling pathway (14). Thus, EP 
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shows considerable potential as a drug for lung tissue repair accompanied with 
anti6inflammatory responses through regulation of the HMGB1/RAGE pathway. 
     In the present study, we demonstrate the observation of disease progression in a 
mouse model of COPD induced by cigarette smoke (CS) exposure and 
lipopolysaccharide (LPS) instillation, as measured by HPXe MRI.  Additionally, the 
efficacy of ethyl pyruvate (EP) for treatment of this COPD model is studied to assess 
the feasibility of  this non6invasive imaging technique as a diagnostic method for early 
disease detection and therapy response evaluation in COPD. 
 
)*&' 



Thirty6seven male, 66week6old, type ddY mice, weighing 30 – 35 g (Japan SLC, Inc., 
Shizuoka, Japan) were included in this study. All experimental procedures and animal 
care standards conformed to Osaka University guidelines. Mice were divided into two 
groups: a sham6instilled group of N=5 mice and a CS and LPS group of N=32. The CS 
and LPS mice were further divided into 2 equal  groups of 16 individuals.  The two 
subgroups were separately administered with a combination of  CS and LPS as follows. 
CS of approximately 2.1 L in volume resulting from one cigarette (Lark Milds: tar 9 
mg, nicotine 0.8 mg; Philip Morris International Inc.,  New York, USA) was collected 
into a Tedlar® bag (Sigma6Aldrich, St Louis,  MO, USA). The mice in each subgroup 
were placed in a semi6sealed plastic container with a volume of 12.4 L and 9 airshafts 
of 5 mm inner diameter on its upper surface. CS was flowed from the Tedlar® bag into 
the container for 26 minutes at a rate of 40 mL/min. Following this, fresh room air was 
flowed into the container for 5 minutes (at 720 mL/min). This whole6body exposure 
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procedure was performed twice daily on five consecutive days within one week, and 
repeated on a weekly basis as described below. On each fifth day, a 20 LL solution of 
LPS in saline (0.4 mg/kg, LPS in  		
 	 ,  serotype O55:B5, Sigma6Aldrich, 
St. Louis, MO, USA) was delivered intra6tracheally to the mice at least  2 hours prior  
to the CS exposure. The sham6instilled mice were intra6tracheally administered with 
2 0  L L  of saline on every fifth day in the same manner as the LPS administration. 
     Six weeks after commencing CS and LPS exposure, the two subgroups of CS and 
LPS mice were assigned as follows: a pure CS and LPS group of N=16 mice and an 
EP6treated group of N=16 mice. For the pure CS and LPS group, the same protocol of 
CS and LPS administration was continued for  a further 4 weeks. EP6treated mice were 
intra6tracheally administered with a 20 LL solution of EP in sal ine (1.3 mg/kg, Tokyo 
Chemical Industry Ltd, Tokyo, Japan) on a daily basis for 4 weeks, in addition to the 
continued administration of CS and LPS as detailed above. EP was always 
administered after the CS and LPS exposure, separated by an interval of at  least  2 
hours. Therefore, in total, 10 weeks were required to completely prepare the CS and 
LPS, and EP6treated groups. The sham6instilled mice were intra6tracheally 
administered with 2 0  L L  of saline per day, every weekday, for this 4 week period, in 
the same manner as the EP treatment.  The survival rates of the whole 106week 
procedure were 75% for CS and LPS mice (12 out of 16 mice survived), 75% for 
EP6treated mice (12 out of 16 mice survived), and 100 % for the sham6instilled group. 
     In all cases, prior to the instillation of saline, LPS or EP solution, mice were 
anesthetized with 2% isoflurane (ISOFLU®, Dainippon Sumitomo Pharmaceutical Co. 
Ltd, Osaka, Japan), which was administered via a nose cone using a home6built 
anesthesia system connected to an isoflurane vaporizer (Isorex I6200, Shin6Ei 
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Industries, Inc., Tokyo, Japan). Subsequently, mice were intubated with a 22 G 
catheter (SURFLO® F&F, Terumo Corp., Tokyo, Japan) while positioned supine and 
secured to a slanted wooden board, and then the saline, LPS or EP solution was 
instilled. 
MR measurements of sham6instilled and CS and LPS groups were performed at 0 
weeks (prior to the first administration) and 2, 6, 8 and 10 weeks after commencing the 
administration of CS and LPS. Similarly, MR measurements of the EP6treated group 
were performed at 0, 6,  8 and 10 weeks after commencing the administration of CS and 
LPS (i.e. 66, 0, 2 and 4 weeks from commencement of EP therapy). Immediately before 
all MR measurements, mice were anesthetized with 2% isoflurane as detailed above. A 
plastic mouth mask, to which three polyethylene tubes were connected (for HPXe gas 
delivery,  O2  delivery and exhaled gas exhaust), was attached to the animal prior to 
placement in the MR scanner. In order to synchronize image acquisitions with 
respiratory motion, a pulse transducer (AD Instruments Ltd., Dunedin, New Zealand) 
was positioned on the mouse abdomen, just  inferior to the diaphragm. This sensor 
converted the respiratory motion into an electrical signal that was monitored in 
real6time using LabVIEW software (National Instruments,  Austin, TX, USA). The 
animal’s body temperature in the magnet was maintained with warm water circulating 
through a rubber tube placed on the abdomen. The MR imaging procedure was 
performed without tracheal intubation or  tracheotomy and hence was entirely 
non6invasive. 
 

"+	'
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129
Xe nuclei were polarized to ~10% by Rb6
12 9
Xe spin6exchange optical pumping (25) 
with a home6built continuous6flow 
12 9
Xe polarizer (26).  A gas mixture consisting of  
70% Xe (natural  abundance, comprising 26% 
1 29
Xe) and 30% N2  was supplied from a 
pre6mixed cylinder (Air Liquid Japan Ltd.,  Tokyo, Japan) at a pressure of 0.15 
atmospheres for 
1 2 9
Xe polarization. Once polarized, HPXe was subsequently 
compressed to atmospheric pressure with a diaphragm pump (LABOPORT® N86 
KN.18, KNF Neuberger GmbH, Freiburg, Germany) to facilitate gas delivery directly 
and continuously from the polarizing cell to the mouse in the magnet. The HPXe gas 
mixture was flowed continuously at a rate of 50 mL/min to each mouse and was mixed 
with O2  (continuously supplied at 9 mL/min) in the mouth mask. The percentages of 
Xe and O2  spontaneously inhaled by the mice were 59.3% and 15.3%, respectively. 
 
,,
All MR measurements were performed on a Agilent Unity INOVA 400 WB 
high6resolution NMR spectrometer system running VNMR 6.1C software (Varian Inc., 
Palo Alto, CA, USA). A 9.4 T vertical magnet with a bore width of 89 mm (Oxford 
Instruments Plc., Oxford, UK) was used. A self6shielded gradient probe was employed 
in combination with Litz volume RF coils of 34 mm inner diameter,  tunable to the 
Larmor frequencies of 
1 29
Xe (110.6 MHz) and 
1
H (399.6 MHz) (Clear Bore DSI61117, 
Doty Scientific, Inc.,  Columbia, SC, USA). 
For assessment of  pulmonary ventilation and gas6exchange function, HPXe gas 
images were acquired with a 2D multi6shot balanced steady6state free precession 
(bSSFP) sequence, which was programmed in6house (27). Acquisi tion parameters were 
as follows: RF pulse, 1000 Ls long Gaussian6shaped pulse with a bandwidth of 2800 
Hz and centered on the 
12 9
Xe gas6phase resonance (0 ppm); TR/TE, 3.2/1.6 ms; 
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receiver bandwidth, 62 kHz; one coronal slice of thickness 20 mm, covering the whole 
of the lungs; matrix size, 64 × 32; field of view, 80 × 25.6 mm
2
;  number of shots 
(required to fill  k6space), 4; fl ip angle, 40º; number of averages of the whole 
acquisition, 8; centrically6ordered phase encoding. 
1 2 9
Xe images were reconstructed 
by a 2D fast Fourier transform after zero fil ling to a 128 × 64 matrix using in6house 
MATLAB scripts (MathWorks Inc., Natick,  MA, USA). 
 
)
For evaluating pulmonary ventilation function, the fractional  ventilation (i.e.  the 
fraction of gas “turned over” per breathing cycle), 
 ,  was mapped across the lungs 
following a previously reported method (28,29). Briefly, after  the HPXe concentration 
in the lungs had reached a steady6state under the continuous supply of HPXe and O2 , 
two pre6saturation RF pulses were applied at  the 
1 2 9
Xe gas6phase frequency to destroy 
any gas6phase 
1 29
Xe magnetization in the alveoli. The bSSFP imaging sequence was 
then used to acquire respiratory6synchronized 
1 2 9
Xe gas ventilation images at 
inspiration after   breathing cycles. The value of   was sequentially incremented from 
1 to 10, and then to 12, 15 and 20; thus, thirteen 
1 2 9
Xe ventilation images were 
acquired in total.  (In Reference (28), images were acquired after 1 to 10 breaths only;  
the purpose of the additional acquired images here was to improve the accuracy of the 

  estimate.) From the resulting image series,  the fractional ventilat ion  of each voxel 
was evaluated by analyzing the dependency of  the 
1 2 9
Xe MR signal intensity upon the 
number of breaths (Equations 2 and 3, Reference (28)). The fractional ventilation, 
 , 
is defined as:  








 ,     [1] 
Page 9 of 60
Magnetic Resonance in Medicine
Magnetic Resonance in Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
10 
 
where o  and  f  denote the volumes of  old and new (fresh) gas within the voxel  after 
each breath, respectively. 
  values were determined pixel6by6pixel over the whole 
image to derive a 
  map, and averaged for each mouse to obtain the whole lung 
 . 
Finally, the whole lung 
  values were averaged for each of the sham6instilled, CS and 
LPS, and EP6treated groups to obtain group mean 
  values. 
 
),	-.,  
The efficiency of HPXe gas6exchange between the alveoli (gas6phase) and the lung 
parenchyma and capillaries (dissolved6phase) was evaluated by the xenon polarization 
transfer contrast  (XTC) method (30). Briefly, a XTC image was generated by acquiring 
bSSFP gas ventilation images at expiration, separated by the application of four 
frequency6selective inversion pulses (inter6pulse delay 20 ms) at the Larmor 
frequency of dissolved6phase 
12 9
Xe (197 ppm), and comparing the resulting ventilation 
image intensities (27). The flip angle of the inversion pulse (Gaussian6shape; 1000 Ls 
duration) was calibrated prior to the present study. Similarly, a “control” bSSFP image 
was generated by acquiring ventilation images at expiration, separated by the 
application of the same inversion pulses, but centered at 6197 ppm instead of 197 ppm. 
The whole XTC measurement was repeated three times, and the three images were 
summed to improve image SNR. The parameter of gas6exchange function,  ,  defined 
as the fractional depolarization of gas6phase HPXe caused by the repeated RF 
inversion of dissolved6phase HPXe during continuous diffusive exchange of xenon 
between the two compartments,  was calculated according to the ratio of the signal 
intensities of control and XTC images as follows: 
(%) = 1 − 
 
  × 100	                       [2] 
where  and      are the signal intensities of XTC and control images, 
Page 10 of 60
Magnetic Resonance in Medicine
Magnetic Resonance in Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
11 
 
respectively, and   is the number of  inversion pulses.   values were calculated on a 
pixel6by6pixel basis in order to create a whole lung   map. As with the 
  analysis,  
mean   values were obtained for  each of the sham6instilled,  CS and LPS,  and 
EP6treated groups. 
 
For each of the above described techniques, the existence of statistically6significant  
differences in mean values of derived parameters between groups was assessed by the 
analysis of  variance (ANOVA)method with the Tukey6Kramer test, using the JMP 
Statistics package (SAS Institute Inc., Cary, NC, USA). 
 
*	,		
After completion of  the MR experiments (week 10), the mice were euthanized with a 
lethal dose of carbon dioxide gas. Lungs were extracted and fixed in a 10 % formalin 
solution,  and hematoxylin and eosin (H&E) stained slides were created to analyze 
morphological changes to the alveoli and terminal bronchioles. Four slides per mouse 
were used to evaluate structural parameters including mean linear intercept (MLI) and 
mean bronchial  wall thickness (),  as previously described (31).  Five MLI and   
values were calculated from each slide, corresponding to the five lobar regions of  the 
lung (right upper lobe, right  middle lobe and right lower lobe; left upper lobe and left 
lower lobe). Each set of five values was averaged over the four slides, and then the 
resulting five averaged regional MLI and   values were in turn averaged to yield a 
single MLI and   value for each mouse. Mean MLI and   values were calculated for 
each of the sham6instil led, CS and LPS, and EP6treated groups in this manner.  
     In order to monitor morphological changes during the 10 weeks of CS and LPS 
administration, one additional CS and LPS histological  analysis group (N=3 mice) was 
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prepared after 4 weeks of administration using the same protocol as described above. 
MLI and   values were evaluated for these groups as described above.  
 
) (/  
Figures 1 and 2 show the longitudinal changes in 
  and   maps, respectively, after  0, 
6,  8 and 10 weeks of CS and LPS administration, for one representative mouse from 
each of the sham6instil led, CS and LPS, and EP6treated groups. It should be noted that 
Figures 1 and 2 were additionally processed with a 2 x 2 median filter using ImageJ 
(National  Institute of Health) to reduce the prevalence of art ifacts associated with 
cardiac motion and rapid diffusion of HPXe in the major airways. These maps depict 
the regional variation in pulmonary ventilation and gas6exchange functional changes 
over time. In particular, they highlight an approximately spatially homogeneous 
reduction of 
  in the CS and LPS mice after 10 weeks, and an overall improvement in 

  and   in response to EP therapy, with some regional heterogeneity. 
Figures 3 and 4 display the group6mean values of 
  and  ,  respectively, after 0, 
2,  6,  8 and 10 weeks of CS and LPS exposure. The mean 
  value for the CS and LPS 
group was found to be significantly decreased compared to that of the sham6instilled 
group after 6 weeks ( < 0.05), and was observed to continue to decrease for the 
remainder of  the 10 week measurement period (after 10 weeks, 
   = 0.19 ± 0.03, 
compared with 
   
  	   	     = 0.25 ± 0.03,  < 0.01). The mean 
  value of the EP 
group was comparable to that  of the sham6instilled mice (
  = 0.25 ± 0.03) after 10 
weeks, i .e. 4 weeks of  EP administration. This value is also significantly larger than 
that of the CS and LPS group;  < 0.01. The   value of the CS and LPS group 
(  = 4.5 ± 1.1 %) was significantly lower ( < 0.01) than that of the 
sham6instilled group (
 	   	     = 6.8 ± 0.6 %) after 10 weeks of exposure to CS 
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and LPS, while the   value of the EP group was considerably improved (  = 6.2 ± 
0.9 %) compared with that of the CS and LPS group (  < 0.01). The longitudinal 
variation in mean 
  and   values from all groups was found to correlate significantly 
(Pearson’s   = 0.820,   < 0.01).  
Figures 5 and 6 depict  whole lung mean MLI and   values and representative 
histological images obtained from mice from each of the sham6instilled, EP6treated 
and CS and LPS groups at the end of the 10 week experimental protocol,  and the 
histological analysis group, respectively. As illustrated in these figures, an 
enlargement of the alveolar airspace volume was observed at week 10 following 
bronchial wall thickening; this is discussed below. The mean MLI of the CS and LPS 
group (  = 44.0 ± 3.8 Lm) was significantly larger than that of the 
sham6instilled group (
	   	    = 39.7 ± 1.8 Lm,  < 0.05).  The mean MLI of the 
EP6treated group ( = 38.2 ± 2.4 Lm) was smaller than that of  the CS and LPS 
group ( < 0.01) and similar to that of the sham6instilled group. The   value of the 
EP6treated group (  = 12.5 ± 1.1 Lm) was smaller than that of the CS and LPS group 
(  = 14.9 ± 1.3 Lm,   < 0.01), and similar  to that  of the sham6instilled group 
(
 	   	     = 12.3 ± 0.6 Lm) at week 10. Meanwhile, the mean MLI and   values of 
the histological analysis group (exposed to CS and LPS for 4 weeks) were !"# = 
39.8 ± 2.5 Lm and  !"# = 14.1 ± 0.6 Lm, respectively, which were comparable to 
those of  the sham6insti lled mice.  
     Figure 7 shows correlat ion plots of individual 
 ,     and MLI values obtained 
from the sham6instilled,  EP6treated and CS and LPS mice after the 10 week 
experimental protocol. Significant posit ive correlations were observed between 
  and 
 ,  and MLI and  ,  as were significant negative correlations between  
  and  ,    and  , 
and   and MLI (  < 0.05). The correlat ion between 
  and MLI was not statis tically 
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significant (  > 0.05).  
 
' !(  &%
In the present study, a murine model of  COPD was developed by 10 weeks of exposure 
to CS and LPS, and the associated induced temporal changes of pulmonary ventilation 
and gas6exchange function were assessed noninvasively by HPXe MRI. The present 
COPD model was able to induce characteristic emphysematous alveolar tissue 
destruction, achieved by modifying previous protocols for producing airway 
inflammation using CS and LPS (21,32,33). The longitudinal HPXe MRI assessment of  
pulmonary function revealed a significant decrease in parameters of both fractional 
ventilation, 
 , and gas6exchange,   of the CS and LPS mice after  6 weeks of CS and 
LPS exposure. However, for the first 2 weeks, pulmonary function in these mice was 
not notably different from that  of sham6insti lled mice. The longitudinal  variation in 
the mean values of the two parameters was found to correlate, suggesting that the 
time6course of disease progression acted to simultaneously impair both ventilation and 
gas6exchange function. In addition, the 
  and   values were found to correlate 
significantly on a per mouse basis at week 10, although not prior to week 10, which 
supports the decision to end the CS and LPS administration at  this time6point. 
Reductions in   and increases in the prevalence of ventilation defects have been 
previously observed using hyperpolarized gas MRI in human COPD patients (34,35), 
supporting the fact that the CS and LPS model of COPD employed here could 
successfully induce similar pathological  effects to COPD itself. Combining 
whole6body CS exposure with LPS administrat ion induced significant emphysematous 
pathology and bronchial wall thickening after 10 weeks of  exposure,  as illustrated by 
histology slides (Figures 5 and 6).  On the other hand, exposure to only CS has been 
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reported to typically require ≥ 6 months to establish the characteristic emphysematous 
pathology in mice (36). While Hansbro et al.  succeeded to establish a mouse model of 
COPD by 8 weeks of  CS exposure through the nose only, this procedure required 
purpose6built equipment that is not readily translatable to our laboratory, and the CS 
dose was relatively high (2 cigarettes/mouse/day) (37). Thus, our protocol of CS and 
LPS exposure considerably shortened the time required to produce the two phenotypes 
of COPD pathology without necessitating specialist equipment. As such, this 
procedure may be advantageous for future investigations of COPD treatment response. 
     The present COPD mouse model caused significant decreases of ventilation and 
gas6exchange parameters: mean 
  of 0.19 ± 0.03 in CS and LPS mice compared with 
0.25 ± 0.03 in sham6instilled mice;  mean   of 4.5 ± 1.0% compared with 6.8 ± 0.6%, 
respectively, after 10 weeks. The decrease of 
  after 10 weeks of exposure to CS and 
LPS is indicative of an increase in the bronchial wall thickness, and indeed 
 showed 
a significant correlation with the histology6derived   value at this time6point (Figure 
7). However, the decrease of    is indicative of  both a reduction in the volume of 
septal tissue and an increase in the bronchial wall thickness. The decrease in   and 
  
at the 6 week time6point may be attributable to the increase in bronchial wall thickness, 
  (see Supporting Figure S1)  since it is unlikely that the volume of septal tissue 
decreased (as there was no significant change in MLI at the 4 week time6point).  This 
situation may be similar to a previous study in which CS and LPS were administered to 
rats for 6 weeks (21). According to that report, no histological evidence of COPD (i.e. 
MLI change)  despite overexpression of HMGB1. However, it  is worth noting 
that these observations might not exclude the possibility of early stage emphysema, 
because mice lack the anatomical characteristics (respiratory bronchioles) for  
expression of centrilobular emphysema (4). One might also expect that the decrease in 
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  was caused in part  by a reduction in the volume of the pulmonary capillaries, 
because the   measurement includes a contribution related to blood volume (since 
ddY6type mice exhibit only a single NMR peak from dissolved6phase 
12 9
Xe in lung 
tissue and blood (31), and furthermore, the XTC technique as employed herein does 
not enable the distinction of two dissolved6phase 
1 29
Xe compartments even if they 
were present).  
     In the present study, the efficacy of EP for treatment of the CS and LPS model of 
COPD was quantified by longitudinal observations of pulmonary function. The 
reductions in 
  and   in the CS and LPS group after  6 weeks recovered to a similar  
level as the sham6instilled group by 2 and 4 weeks of  administration of EP, 
respectively ( < 0.01, see Figures 3 and 4). Because the administration of EP was 
only started 6 weeks after commencement of CS and LPS exposure (i.e.  after some 
impairment of pulmonary function was observed), EP likely exhibited a combination 
of both preventative and therapeutic properties in the CS and LPS model of COPD. In 
other words, EP may have acted to inhibit further emphysema development and to 
repair the existing bronchial wall damage (Figures 5 and 6). This hypothesis is 
supported by the lack of significant difference in the 
  and   values between 6 and 10 
week time6points in the EP6treated group ( > 0.05).  However, the present study was 
unable to clarify whether the recovery of  HPXe MRI metrics might be indicative of the 
reparation of tissue loss by early emphysema and/or improved pulmonary 
hemodynamics. To prove whether  EP can indeed act to reverse emphysematous tissue 
loss,  further experiments are needed in which EP administration is started after 10 
weeks of CS and LPS exposure. 
     To the best of our knowledge, this is the first evidence of the therapeutic action 
of EP in a murine COPD model, as measured by HPXe MRI. Recently, it  has been 
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reported that intraperitoneal  administration of EP can inhibit the expression of  
HMGB1 (18,19). Additionally,  high expression of HMGB1 has been reported to lead to  
lung functional impairment,  and is associated with the development and progression of  
COPD (20622). On the other hand, albeit paradoxically, the HMGB1/RAGE pathway is 
also known to be associated with a series of signalling pathways for  tissue repair 
(23,24). It  may be speculated that  EP is effective in treating lung diseases caused by 
chronic inflammation (such as the CS and LPS model of COPD) through the regulation 
of HMGB1/RAGE, leading to improvement and potentially maintenance of  murine 
pulmonary function. Further studies with corresponding molecular assays are required 
to substantiate this claim. 
 
!&%!/( &%
The feasibility of HPXe MRI for longitudinal  assessment of disease progression and 
pharmacological therapy has been demonstrated in a mouse model of COPD. The 
model, combining exposure to cigarette smoke and lipopolysaccharide solution, 
induced COPD characteristics in mice in a relatively short time of 10 weeks and offers 
potential advantages for pharmacological therapy assessment applications. HPXe 
MRI6derived metrics of pulmonary function showed considerable impairment in both 
ventilation and gas6exchange function in CS and LPS mice compared with 
sham6instilled mice, as verified by histological analysis. Longitudinal HPXe MRI 
assessment of the action of an anti6inflammatory agent,  ethyl pyruvate, for treatment 
of this COPD model revealed preliminary evidence of its efficacy, and may help to 
elucidate the exact mechanisms of its therapeutic action in the future. 
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Figure legends:  
 
Figure 1. Example parametric maps of  
  derived from longitudinal studies of mice in 
each of the three groups, from top to bottom: sham6instilled; CS and LPS model of 
COPD; EP6treated. In all cases, the time course is shown horizontally. 
 
 
Figure 2. Example parametric maps of    derived from longitudinal  studies of mice in 
each of the three groups, from top to bottom: sham6instilled; CS and LPS model of 
COPD; EP6treated. In all cases, the time course is shown horizontally.  
 
 
Figure 3. Box plots of the temporal change of mean 
  values for all mice, separated by 
group. Significant differences between groups are indicated by solid lines, along with 
the corresponding p values of significance (* < 0.05; **  < 0.01).  
 
 
Figure 4. Box plots of the temporal change of mean   values for all mice, separated by 
group. Significant differences between groups are indicated by solid lines, along with 
the corresponding p values of significance (* < 0.05; **  < 0.01).  
 
 
Figure 5. a) Box plots showing the mean MLI values obtained from mice in each of the 
four groups, from left  to right: sham6instilled;  histological analysis (CS&LPS 4w), CS 
and LPS model of  COPD (CS&LPS10w); EP6treated. b) Representative examples of  
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H&E stained histology slides obtained from 5 lung regions of one mouse chosen from 
each of the four groups. RU, right  upper lobe;  RM, right  middle lobe; RL, right lower 
lobe; LU, upper region of the left lobe; LL, lower region of the left  lobe. Note:  mean 
values in a)  represent the mean of the whole group; mean values in b) represent  the 
mean for the selected mouse from each group. 
 
Figure 6. a) Box plots showing the mean bronchial wall thickness () values obtained 
from mice in each of the four groups, from left to right: sham6insti lled; histological  
analysis (CS&LPS 4w), CS and LPS model of  COPD (CS&LPS10w); EP6treated after  
the 10 week experimental protocol. b)  Representative examples of H&E stained 
histology slides obtained from the four groups.  
 
Figure 7. Relationships between HPXe MRI6derived parameters of  pulmonary function 
(
  and ), and histology6derived parameters of lung structure (MLI and ) obtained 
from the sham6instilled (□), EP6treated (○), and CS and LPS (▲) mice after the 10 
week experimental protocol.  The Pearson’s  value and   value of statistical  
significance are noted in each plot.  
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Supporting Figure S1. a) Box plots showing the mean bronchial wall thickness () 
values obtained from mice in each of the five groups, from left to right: 
sham6instilled; histological analysis (CS&LPS 4w and CS&LPS 6w), CS and LPS 
model of COPD (CS&LPS10w); EP6treated after the 10 week experimental protocol. b) 
Representative examples of H&E stained histology slides obtained from the five 
groups. 
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 !  
"
	#  To investigate disease progression and treatment response in a murine model 
of chronic obstructive pulmonary disease (COPD) using a preclinical hyperpolarized 
129
Xe (HPXe) MRI strategy.  
	#  COPD phenotypes were induced in 32 mice by 10 weeks of exposure to 
cigarette smoke (CS) and lipopolysaccharide (LPS). The efficacy of ethyl pyruvate 
(EP), an anti6inflammatory drug, was investigated by administering EP to 16 of the 32 
mice after 6 weeks of CS and LPS exposure. HPXe MRI was performed to monitor 
changes in pulmonary function during disease progression and pharmacological 
therapy.  
		#  HPXe metrics of fractional ventilation and gas6exchange function were 
significantly reduced after 6 weeks of CS and LPS exposure compared to 
sham6instilled mice administered with saline (  < 0.05). After this observation, EP 
administration was started in 16 of the 32 mice and continued for 4 weeks. EP was 
found to improve HPXe MRI metrics to a similar level as in sham6instilled mice (  < 
0.01). Histological  analysis showed significant alveolar tissue destruction in the 
COPD group, but relatively normal alveolar structure in the EP and sham6instilled 
groups. 
!	#  This study demonstrates the potential efficacy of EP for COPD therapy, 
as assessed by a non6invasive, translatable 12 9Xe MRI procedure. 

	$#  200 
Keywords: Hyperpolarized 
1 2 9
Xe MRI, lung functional assessment, murine chronic 
obstructive pulmonary disease, treatment response, ethyl pyruvate 
 
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%&'(!&%
Chronic obstructive pulmonary disease (COPD), a heterogeneous lung disease 
characterized by both chronic airway inflammation and emphysematous alveolar tissue 
destruction, is predicted to be the third leading cause of death worldwide by 2020 (1). 
At present,  pharmacological therapies for COPD have shown limited efficacy and thus 
the development of new therapeutic drugs is vital for improving patient outcomes (2). 
The use of appropriate animal models of COPD that adequately induce the key 
symptoms of the disease is indispensable for therapy development, and rodent models 
are especially important.  In particular, preclinical studies with mice are often 
appropriate because a wide range of well6characterized disease models are available 
(3,4). As smoking and repeated lung infections are the primary causes of COPD, 
several murine COPD models have been developed by exposing mice to  cigarette 
smoke. Despite certain models showing good reproducibility for  inducing the two 
main phenotypes of COPD mentioned above, the lack of applicable methods for 
assessment and diagnosis of these disease models remains a limiting factor for 
preclinical studies. Most previous studies have relied on plethysmography and/or 
histology to evaluate the applicability of murine COPD models, necessitating a 
tracheostomy and/or mouse death for each examination (5,6) and hence making it  
difficult to evaluate drug efficacy repetitively and longitudinally. To help resolve this 
problem, non6invasive imaging techniques that allow the longitudinal assessment of 
disease progression and therapeutic efficacy of drugs in vivo are required.  
     MRI using hyperpolarized (HP) noble gases (
3
He and 
129
Xe) as contrast agents 
offers an attractive means to visualize and quantitatively evaluate pulmonary 
functional parameters such as ventilation and gas6exchange (769). In a number of 
studies in small animals and humans, pathological changes of these fundamental 
	
	
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parameters have been investigated using HP gas MRI and quantitative measures of 
ventilation and gas6exchange dysfunction caused by COPD have been established 
(10,11). HP 1 29Xe (HPXe) is a versatile contrast agent to evaluate drug efficacy in the 
lungs because it  allows not only imaging of ventilation, but also the assessment of 
pulmonary gas6exchange, thanks to its solubility in pulmonary tissues and blood. To 
this end, we have developed a continuous6flow mode polarizer for  HPXe production 
and have established non6invasive MRI procedures under spontaneous respiration for 
the assessment of pulmonary function in mice (12,13). In  this study, we apply our 
HPXe methodology to explore the feasibility of a new drug for COPD therapy. 
     Ethyl pyruvate (EP), an anti6inflammatory agent, is a candidate for 
pharmacological therapy of COPD. In recent years, EP has been shown to demonstrate 
therapeutic efficacy in various animal models of lung diseases, such as acute lung 
injury (ALI) and pulmonary arterial hypertension (PAH) (15617). The therapeutic 
efficacy of EP is attributed to its ability to regulate high6mobility group box protein61 
(HMGB1) release from innate immune cells,  and to deactivate subsequent cytokine 
production that would further stimulate inflammatory responses (18,19). HMGB1, 
which is  an abundant chromatin  protein, may play a crucial role in pharmacological  
therapy of COPD because it  is known to not only trigger inflammatory responses but 
also, paradoxically, to activate cells involved in tissue repair (20624). HMGB1 
functions by binding with the receptor for advanced glycation end products (RAGE) 
and Toll6Like Receptors 2 and 4. In recent years, it  has been shown that HMGB1 can 
also initiate wound healing processes through binding with RAGE followed by 
activation of the extracellular signal6regulated kinase 1/2 (ERK1/2) signaling pathway 
(23). RAGE is expressed in  pulmonary tissues with relatively high basal levels (22), 
and EP has been reported to activate the ERK1/2 signaling pathway (14). Thus, EP 
	

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shows considerable potential as a drug for lung tissue repair accompanied with 
anti6inflammatory responses through regulation of the HMGB1/RAGE pathway. 
     In the present study, we demonstrate the observation of disease progression in a 
mouse model of COPD induced by cigarette smoke (CS) exposure and 
lipopolysaccharide (LPS) instillation, as measured by HPXe MRI. Additionally, the 
efficacy of ethyl pyruvate (EP) for treatment of this COPD model is studied to assess 
the feasibility of this non6invasive imaging technique as a diagnostic method for early 
disease detection and therapy response evaluation in COPD. 
 
)*&' 



Thirty6seven male, 66week6old, type ddY mice, weighing 30 – 35 g (Japan SLC, Inc.,  
Shizuoka, Japan) were included in this study. All experimental procedures and animal  
care standards conformed to Osaka University guidelines. Mice were divided into two 
groups: a sham6instilled group of N=5 mice and a CS and LPS group of N=32. The CS 
and LPS mice were further divided into 2 equal groups of 16 individuals. The two 
subgroups were separately administered with a combination of CS and LPS as follows. 
CS of approximately 2.1 L in volume resulting from one cigarette (Lark Milds: tar 9 
mg, nicotine 0.8 mg; Philip Morris International Inc.,  New York, USA) was collected 
into a Tedlar® bag (Sigma6Aldrich, St Louis, MO, USA).  The mice in each subgroup 
were placed in a semi6sealed plastic container with a volume of 12.4 L and 9 airshafts 
of 5 mm inner diameter on its upper surface. CS was flowed from the Tedlar® bag into 
the container for 26 minutes at a rate of 40 mL/min. Following this, fresh room air was 
flowed into the container for 5 minutes (at 720 mL/min). This whole6body exposure 
	

Page 31 of 60
Magnetic Resonance in Medicine
Magnetic Resonance in Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
6 
 
procedure was performed twice daily on five consecutive days within one week, and 
repeated on a weekly basis as described below. On each fifth day, a 20 LL solution of 
LPS in saline (0.4 mg/kg, LPS in  		
 	 , serotype O55:B5, Sigma6Aldrich,  
St. Louis, MO, USA) was delivered intra6tracheally to the mice at least 2 hours prior 
to the CS exposure. The sham6instilled mice were intra6tracheally administered with 
2 0  L L of saline on every fifth  day in the same manner as the LPS administration. 
     Six weeks after commencing CS and LPS exposure, the two subgroups of CS and 
LPS mice were assigned as follows:  a pure CS and LPS group of N=16 mice and an 
EP6treated group of N=16 mice. For the pure CS and LPS group, the same protocol of 
CS and LPS administration was continued for a further 4 weeks. EP6treated mice were 
intra6tracheally administered with a 20 LL solution of EP in saline (1.3 mg/kg, Tokyo 
Chemical Industry Ltd, Tokyo, Japan) on a daily basis for 4 weeks, in addition to the 
continued administration of CS and LPS as detailed above. EP was always 
administered after the CS and LPS exposure, separated by an interval of at least  2 
hours. Therefore, in total, 10 weeks were required to completely prepare the CS and 
LPS, and EP6treated groups. The sham6instilled mice were intra6tracheally 
administered with 2 0  L L of saline per day, every weekday, for this 4 week period, in 
the same manner as the EP treatment. The survival rates of the whole 106week 
procedure were 75% for CS and LPS mice (12 out of 16 mice survived), 75% for 
EP6treated mice (12 out of 16 mice survived), and 100 % for the sham6instilled group. 
     In all cases, prior to the instillation of saline, LPS or EP solution, mice were 
anesthetized with 2% isoflurane (ISOFLU®, Dainippon Sumitomo Pharmaceutical Co. 
Ltd, Osaka, Japan), which was administered via a nose cone using a home6built 
anesthesia system connected to an isoflurane vaporizer (Isorex I6200, Shin6Ei 
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Industries, Inc., Tokyo, Japan). Subsequently, mice were intubated with  a 22 G 
catheter (SURFLO® F&F, Terumo Corp.,  Tokyo, Japan) while positioned supine and 
secured to a slanted wooden board, and then the saline, LPS or EP solution was 
instilled. 
MR measurements of sham6instilled and CS and LPS groups were performed at 0 
weeks (prior to the first administration) and 2, 6, 8 and 10 weeks after commencing the 
administration of CS and LPS. Similarly, MR measurements of the EP6treated group 
were performed at 0, 6, 8 and 10 weeks after commencing the administration of CS and 
LPS (i.e. 66, 0, 2 and 4 weeks from commencement of EP therapy). Immediately before 
all MR measurements, mice were anesthetized with 2 % isoflurane as detailed above. A 
plastic mouth mask, to which three polyethylene tubes were connected (for HPXe gas 
delivery, O2  delivery and exhaled gas exhaust),  was attached to the animal prior to 
placement in the MR scanner. In order to synchronize image acquisitions with 
respiratory motion, a pulse transducer (AD Instruments Ltd.,  Dunedin, New Zealand) 
was positioned on the mouse abdomen, just inferior to the diaphragm. This sensor 
converted the respiratory motion into an electrical signal that was monitored in 
real6time using LabVIEW software (National Instruments, Austin, TX, USA). The 
animal’s body temperature in the magnet was maintained with warm water circulating 
through a rubber tube placed on the abdomen. The MR imaging procedure was 
performed without tracheal intubation or tracheotomy and hence was entirely 
non6invasive. 
 

"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129Xe nuclei were polarized to ~10% by Rb612 9Xe spin6exchange optical pumping (25) 
with a home6built continuous6flow 1 29Xe polarizer (26). A gas mixture consisting of 
70% Xe (natural  abundance, comprising 26% 12 9Xe) and 30% N2 was supplied from a 
pre6mixed cylinder (Air Liquid Japan Ltd.,  Tokyo, Japan) at a pressure of 0.15 
atmospheres for 
1 29
Xe polarization. Once polarized, HPXe was subsequently 
compressed to atmospheric pressure with a diaphragm pump (LABOPORT® N86 
KN.18, KNF Neuberger GmbH, Freiburg, Germany) to facilitate gas delivery directly 
and continuously from the polarizing cell to the mouse in the magnet. The HPXe gas 
mixture was flowed continuously at a rate of 50 mL/min to  each mouse and was mixed 
with O2 (continuously supplied at 9 mL/min) in the mouth mask. The percentages of 
Xe and O2 spontaneously inhaled by the mice were 59.3% and 15.3%, respectively. 
 
,,
All  MR measurements were performed on a Varian Unity INOVA 400 WB 
high6resolution NMR spectrometer system running VNMR 6.1C software (Varian Inc.,  
Palo Alto, CA, USA). A 9.4 T vertical magnet with a bore width of 89 mm (Oxford 
Instruments Plc., Oxford, UK) was used. A self6shielded gradient probe was employed 
in combination with Litz volume RF coils  of 34 mm inner diameter,  tunable to the 
Larmor frequencies of 129Xe (110.6 MHz) and 1H (399.6 MHz) (Clear Bore DSI61117, 
Doty Scientific, Inc.,  Columbia, SC, USA). 
For assessment of pulmonary ventilation and gas6exchange function, HPXe gas 
images were acquired with a 2D multi6shot balanced steady6state free precession 
(bSSFP) sequence, which was programmed in6house (27). Acquisition parameters were 
as follows: RF pulse, 1000 Ls long Gaussian6shaped pulse with a bandwidth of 2800 
Hz and centered on the 12 9Xe gas6phase resonance (0 ppm); TR/TE, 3.2/1.6 ms; 
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receiver bandwidth, 62 kHz; one coronal slice of thickness 20 mm, covering the whole 
of the lungs; matrix size, 64 × 32; field  of view, 80 × 25.6 mm2 ;  number of shots 
(required to fill  k6space), 4; flip angle, 40º; number of averages of the whole 
acquisition, 8; centrically6ordered phase encoding. 
1 29
Xe images were reconstructed 
by a 2D fast Fourier transform after zero filling to a 128 × 64 matrix using in6house 
MATLAB scripts (MathWorks Inc.,  Natick, MA, USA).  
 
)
For evaluating pulmonary ventilation function, the fractional ventilation (i.e.  the 
fraction of gas “turned over” per breathing cycle), 
,  was mapped across the lungs 
following a previously reported method (28,29). Briefly, after  the HPXe concentration 
in the lungs had reached a steady6state under the continuous supply of HPXe and O2,  
two pre6saturation RF pulses were applied at the 1 2 9Xe gas6phase frequency to destroy 
any gas6phase 1 2 9Xe magnetization in the alveoli. The bSSFP imaging sequence was 
then used to acquire respiratory6synchronized 12 9Xe gas ventilation images at 
inspiration after   breathing cycles. The value of   was sequentially incremented from 
1 to 10, and then to 12, 15 and 20; thus, thirteen 
12 9
Xe ventilation images were 
acquired in total.  (In Reference (28), images were acquired after 1 to 10 breaths only;  
the purpose of the additional acquired images here was to improve the accuracy of the 

 estimate.) From the resulting image series, the fractional ventilation  of each voxel 
was evaluated by analyzing the dependency of the 1 29Xe MR signal intensity upon the 
number of breaths (Equations 2 and 3, Reference (28)). The fractional ventilation, 
, 
is defined as: 








 ,      [1] 
	

	

	
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where  o and  f denote the volumes of old and new (fresh) gas within the voxel after 
each breath, respectively. 
  values were determined pixel6by6pixel over the whole 
image to derive a 
 map, and averaged for each mouse to obtain the whole lung 
.  
Finally, the whole lung 
 values were averaged for each of the sham6instilled, CS and 
LPS, and EP6treated groups to obtain group mean 
  values. 
 
),	-.,  
The efficiency of HPXe gas6exchange between the alveoli (gas6phase) and the lung 
parenchyma and capillaries (dissolved6phase) was evaluated by the xenon polarization 
transfer contrast (XTC) method (30). Briefly,  a XTC image was generated by acquiring 
bSSFP gas ventilation images at expiration, separated by the application of four 
frequency6selective inversion pulses (inter6pulse delay 20 ms) at the Larmor 
frequency of dissolved6phase 1 2 9Xe (197 ppm), and comparing the resulting ventilation 
image intensities (27). The flip angle of the inversion pulse (Gaussian6shape; 1000 Ls 
duration) was calibrated prior to the present study. Similarly, a “control” bSSFP image 
was generated by acquiring ventilation images at expiration, separated by the 
application of the same inversion pulses, but centered at 6197 ppm instead of 197 ppm. 
The whole XTC measurement was repeated three times,  and the three images were 
summed to improve image SNR. The parameter of gas6exchange function,  , defined 
as the fractional depolarization of gas6phase HPXe caused by the repeated RF 
inversion of dissolved6phase HPXe during continuous diffusive exchange of xenon 
between the two compartments, was calculated according to the ratio of the signal 
intensities of control and XTC images as follows: 
(%) = 1 − 
 
  × 100	                       [2] 
where   and       are the signal intensities of XTC and control images, 
	

	
 	
	
 
Page 36 of 60
Magnetic Resonance in Medicine
Magnetic Resonance in Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
11 
 
respectively, and   is the number of inversion pulses.   values were calculated on a 
pixel6by6pixel basis in order to create a whole lung   map. As with the 
  analysis,  
mean   values were obtained for each of the sham6instilled, CS and LPS, and 
EP6treated groups. 
 
For each of the above described techniques, the existence of statistically6significant 
differences in mean values of derived parameters between groups was assessed by the 
analysis of variance (ANOVA) method with the Tukey6Kramer test,  using the JMP 
Statistics package (SAS Institute Inc.,  Cary, NC, USA). 
 
*	,		
After completion of the MR experiments (week 10), the mice were euthanized with a 
lethal dose of carbon dioxide gas. Lungs were extracted and fixed in a 10 % formalin 
solution, and hematoxylin and eosin (H&E) stained slides were created to  analyze 
morphological changes to the alveoli and terminal bronchioles. Four slides per mouse 
were used to evaluate structural parameters including mean linear intercept (MLI) and 
mean bronchial wall thickness (),  as previously described (31). Five MLI and   
values were calculated from each slide, corresponding to the five lobar regions of the 
lung (right upper lobe, right middle lobe and right lower lobe; left upper lobe and left 
lower lobe). Each set of five values was averaged over the four slides, and then the 
resulting five averaged regional MLI and   values were in turn averaged to yield a 
single MLI and   value for each mouse. Mean MLI and   values were calculated for 
each of the sham6instilled, CS and LPS, and EP6treated groups in this manner.  
     In order to monitor morphological changes during the 10 weeks of CS and LPS 
administration, one additional CS and LPS histological analysis group (N=3 mice) was 
	
 
Page 37 of 60
Magnetic Resonance in Medicine
Magnetic Resonance in Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
12 
 
prepared after 4 weeks of administration using the same protocol as described above.  
MLI and   values were evaluated for these groups as described above.  
 
) (/  
Figures 1 and 2 show the longitudinal changes in 
  and   maps, respectively, after  0, 
6, 8 and 10 weeks of CS and LPS administration, for one representative mouse from 
each of the sham6instilled, CS and LPS, and EP6treated groups. It  should be noted that 
Figures 1 and 2 were additionally processed with a 2 x 2 median filter using ImageJ 
(National Institute of Health) to reduce the prevalence of artifacts associated with 
cardiac motion and rapid diffusion of HPXe in the major airways. These maps depict 
the regional variation in pulmonary ventilation and gas6exchange functional changes 
over time. In particular, they highlight an approximately spatially homogeneous 
reduction of 
  in the CS and LPS mice after 10 weeks,  and an overal l improvement in 

 and   in response to EP therapy, with some regional heterogeneity. 
Figures 3 and 4 display the group6mean values of 
  and  , respectively, after 0, 
2, 6, 8 and 10 weeks of CS and LPS exposure. The mean 
  value for the CS and LPS 
group was found to be significantly decreased compared to that of the sham6instilled 
group after 6 weeks (  < 0.05), and was observed to continue to decrease for the 
remainder of the 10 week measurement period (after 10 weeks, 
   = 0.19 ± 0.03, 
compared with 
  
 	  	    = 0.25 ± 0.03,  < 0.01). The mean 
 value of the EP 
group was comparable to that of the sham6instilled mice (
  = 0.25 ± 0.03) after 10 
weeks, i .e. 4 weeks of EP administration. This value is also significantly larger than 
that of the CS and LPS group;  < 0.01. The   value of the CS and LPS group 
(  = 4.5 ± 1.1 %) was significantly lower (  < 0.01) than that of the 
sham6instilled group (
 	   	    = 6.8 ± 0.6 %) after 10 weeks of exposure to CS 
	
 
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and LPS, while the   value of the EP group was considerably improved ( = 6.2 ± 
0.9 %) compared with that of the CS and LPS group (  < 0.01). The longitudinal 
variation in mean 
  and   values from all groups was found to correlate significantly 
(Pearson’s   = 0.820,  < 0.01). 
Figures 5 and 6 depict whole lung mean MLI and   values and representative 
histological images obtained from mice from each of the sham6instilled, EP6treated 
and CS and LPS groups at the end of the 10 week experimental protocol, and the 
histological analysis group, respectively. As illustrated in these figures, an 
enlargement of the alveolar airspace volume was observed at week 10 following 
bronchial wall thickening; this is discussed below. The mean MLI of the CS and LPS 
group (  = 44.0 ± 3.8  Lm) was significantly larger than that of the 
sham6instilled group (
 	   	    = 39.7 ± 1.8 Lm,   < 0.05). The mean MLI of the 
EP6treated group ( = 38.2 ± 2.4 Lm) was smaller than that of the CS and LPS 
group ( < 0.01) and similar to that of the sham6instilled group. The   value of the 
EP6treated group (  = 12.5 ± 1.1 Lm) was smaller than that of the CS and LPS group 
(  = 14.9 ± 1.3 Lm,   < 0.01), and similar to that of the sham6instilled group 
(
 	   	     = 12.3 ± 0.6 Lm) at week 10. Meanwhile, the mean MLI and   values of 
the histological analysis group (exposed to CS and LPS for 4 weeks) were !"# = 
39.8 ± 2.5 Lm and  !"# = 14.1 ± 0.6 Lm, respectively, which were comparable to 
those of the sham6instilled mice.  
     Figure 7 shows correlation plots of individual 
,       and MLI values obtained 
from the sham6instilled, EP6treated and CS and LPS mice after the 10 week 
experimental protocol. Significant positive correlations were observed between 
  and 
 ,  and MLI and  , as were significant negative correlations between  
  and  ,   and ,  
and   and MLI ( < 0.05). The correlation between 
  and MLI was not statistical ly 
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significant (  > 0.05).  
 
' !(  &%
In the present study, a murine model  of COPD was developed by 10 weeks of exposure 
to CS and LPS, and the associated induced temporal changes of pulmonary ventilation 
and gas6exchange function were assessed noninvasively by HPXe MRI. The present 
COPD model was able to induce characteristic emphysematous alveolar tissue 
destruction, achieved by modifying previous protocols for producing airway 
inflammation using CS and LPS (21,32,33). The longitudinal HPXe MRI assessment of 
pulmonary function revealed a significant decrease in parameters of both fractional 
ventilation, 
,  and gas6exchange,   of the CS and LPS mice after 6 weeks of CS and 
LPS exposure. However, for the first 2 weeks, pulmonary function in these mice was 
not notably different from that  of sham6instilled mice. The longitudinal variation in 
the mean values of the two parameters was found to correlate, suggesting that the 
time6course of disease progression acted to simultaneously impair both ventilation and 
gas6exchange function. In addition, the 
 and   values were found to correlate 
significantly on a per mouse basis at week 10, although not prior to week 10, which 
supports the decision to end the CS and LPS administration at this time6point. 
Reductions in   and increases in the prevalence of ventilation defects have been 
previously observed using hyperpolarized gas MRI in human COPD patients (34,35), 
supporting the fact  that the CS and LPS model of COPD employed here could 
successfully induce similar pathological  effects to COPD itself.  Combining 
whole6body CS exposure with LPS administration induced significant emphysematous 
pathology and bronchial wall thickening after 10 weeks of exposure, as illustrated by 
histology slides (Figures 5 and 6). On the other hand, exposure to only CS has been 
	
 
	
 
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reported to typically require ≥ 6 months to establish the characteristic emphysematous 
pathology in mice (36). While Hansbro et al.  succeeded to establish a mouse model of 
COPD by 8 weeks of CS exposure through the nose only, this procedure required 
purpose6built equipment that is not readily translatable to our laboratory, and the CS 
dose was relatively high (2 cigarettes/mouse/day) (37). Thus, our protocol of CS and 
LPS exposure considerably shortened the time required to produce the two phenotypes 
of COPD pathology without necessitating specialist equipment. As such, this 
procedure may be advantageous for future investigations of COPD treatment response. 
     The present COPD mouse model caused significant decreases of ventilation and 
gas6exchange parameters: mean 
 of 0.19 ± 0.03 in CS and LPS mice compared with 
0.25 ± 0.03 in sham6instilled mice; mean   of 4.5 ± 1.0% compared with 6.8 ± 0.6%, 
respectively, after 10 weeks. The decrease of 
 after 10 weeks of exposure to CS and 
LPS is indicative of an increase in the bronchial wall thickness, and indeed 
showed 
a significant correlation with the histology6derived   value at this time6point (Figure 
7). However, the decrease of   is  indicative of both a reduction in the volume of 
septal tissue and an increase in the bronchial wall  thickness. The decrease in   and 
 
at the 6 week time6point may be attributable to the increase in bronchial wall thickness, 
 (see Supporting Figure S1)  since it  is unlikely that the volume of septal tissue 
decreased (as there was no significant change in MLI at the 4 week time6point). This 
situation may be similar to a previous study in which CS and LPS were administered to 
rats for 6 weeks (21). According to that report, no histological evidence of COPD (i.e.  
MLI change)  despite overexpression of HMGB1. However, it  is worth noting 
that these observations might not exclude the possibility of early stage emphysema,  
because mice lack the anatomical characteristics (respiratory bronchioles) for 
expression of centrilobular emphysema (4). One might also expect that the decrease in 
	
 

	
 
	
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  was caused in part by a reduction in the volume of the pulmonary capillaries, 
because the   measurement includes a contribution related to blood volume (since 
ddY6type mice exhibit only a single NMR peak from dissolved6phase 1 2 9Xe in lung 
tissue and blood (31), and furthermore, the XTC technique as employed herein does 
not enable the distinction of two dissolved6phase 
1 2 9
Xe compartments even if they 
were present).  
     In the present study, the efficacy of EP for treatment of the CS and LPS model of 
COPD was quantified by longitudinal observations of pulmonary function. The 
reductions in 
 and   in the CS and LPS group after  6 weeks recovered to a similar  
level as the sham6instilled group by 2 and 4 weeks of administration of EP, 
respectively ( < 0.01, see Figures 3 and 4). Because the administration of EP was 
only started 6 weeks after commencement of CS and LPS exposure (i.e. after some 
impairment of pulmonary function was observed), EP likely exhibited a combination 
of both preventative and therapeutic properties in the CS and LPS model of COPD. In 
other words, EP may have acted to  inhibit further emphysema development and to 
repair the existing bronchial wall damage (Figures 5 and 6). This hypothesis is 
supported by the lack of significant difference in the 
  and  values between 6 and 10 
week time6points in the EP6treated group ( > 0.05). However, the present study was 
unable to clarify whether the recovery of HPXe MRI metrics might be indicative of the 
reparation of tissue loss by early emphysema and/or improved pulmonary 
hemodynamics. To prove whether EP can indeed act to reverse emphysematous tissue 
loss, further experiments are needed in which EP administration is started after 10 
weeks of CS and LPS exposure.  
     To the best of our knowledge, this is the first evidence of the therapeutic action 
of EP in a murine COPD model, as measured by HPXe MRI. Recently, it  has been 
	
 



	
	
 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reported that intraperitoneal administration of EP can inhibit the expression of 
HMGB1 (18,19). Additionally, high expression of HMGB1 has been reported to lead to 
lung functional impairment, and is associated with the development and progression of 
COPD (20622). On the other hand, albeit paradoxically, the HMGB1/RAGE pathway is 
also known to be associated with a series of signalling pathways for tissue repair 
(23,24). It  may be speculated that EP is effective in treating lung diseases caused by 
chronic inflammation (such as the CS and LPS model of COPD) through the regulation 
of HMGB1/RAGE, leading to improvement and potentially maintenance of murine 
pulmonary function. Further studies with corresponding molecular assays are required 
to substantiate this claim. 
 
!&%!/( &%
The feasibility of HPXe MRI for longitudinal assessment of disease progression and 
pharmacological therapy has been demonstrated in a mouse model of COPD. The 
model, combining exposure to cigarette smoke and lipopolysaccharide solution, 
induced COPD characteristics in mice in a relatively short time of 10 weeks and offers 
potential advantages for pharmacological therapy assessment applications. HPXe 
MRI6derived metrics of pulmonary function showed considerable impairment in both 
ventilation and gas6exchange function in CS and LPS mice compared with 
sham6instilled mice, as verified by histological analysis. Longitudinal HPXe MRI 
assessment of the action of an anti6inflammatory agent, ethyl pyruvate, for treatment 
of this COPD model revealed preliminary evidence of its efficacy, and may help to 
elucidate the exact mechanisms of its therapeutic action in the future. 
 
  
	
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Figure legends: 
 
Figure 1. Example parametric maps of 
 derived from longitudinal studies of mice in 
each of the three groups, from top to bottom: sham6instilled; CS and LPS model of 
COPD; EP6treated. In all cases, the time course is shown horizontally. 
 
 
Figure 2. Example parametric maps of   derived from longitudinal studies of mice in 
each of the three groups, from top to bottom: sham6instilled; CS and LPS model of 
COPD; EP6treated. In all cases, the time course is shown horizontally.  
 
 
Figure 3. Box plots of the temporal change of mean 
 values for all  mice, separated by 
group. Significant differences between groups are indicated by solid lines, along with 
the corresponding p values of significance (* < 0.05; **  < 0.01). 
 
 
Figure 4. Box plots of the temporal change of mean   values for all  mice, separated by 
group. Significant differences between groups are indicated by solid lines, along with 
the corresponding p values of significance (* < 0.05; **  < 0.01). 
 
 
Figure 5. a) Box plots showing the mean MLI values obtained from mice in each of the 
four groups, from left to right: sham6instilled; histological analysis (CS&LPS 4w), CS 
and LPS model of COPD (CS&LPS10w); EP6treated. b) Representative examples of 
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H&E stained histology slides obtained from 5 lung regions of one mouse chosen from 
each of the four groups. RU, right upper lobe; RM, right middle lobe; RL, right lower 
lobe; LU, upper region of the left lobe; LL, lower region of the left  lobe. Note: mean 
values in a)  represent the mean of the whole group; mean values in b) represent the 
mean for the selected mouse from each group. 
 
Figure 6. a) Box plots showing the mean bronchial wall thickness () values obtained 
from mice in each of the four groups, from left to right: sham6instilled; histological  
analysis (CS&LPS 4w), CS and LPS model of COPD (CS&LPS10w); EP6treated after  
the 10 week experimental protocol. b) Representative examples of H&E stained 
histology slides obtained from the four groups.  
 
Figure 7. Relationships between HPXe MRI6derived parameters of pulmonary function 
(
 and ), and histology6derived parameters of lung structure (MLI and ) obtained 
from the sham6instilled (□), EP6treated (○), and CS and LPS (▲) mice after the 10 
week experimental protocol. The Pearson’s   value and   value of statistical  
significance are noted in each plot. 
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Supporting Figure S1. a) Box plots showing the mean bronchial wall thickness () 
values obtained from mice in each of the five groups, from left to right: 
sham6instilled; histological analysis (CS&LPS 4w and CS&LPS 6w), CS and LPS 
model of COPD (CS&LPS10w); EP6treated after the 10 week experimental protocol. b) 
Representative examples of H&E stained histology slides obtained from the five 
groups. 
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7. Relationships between HPXe MRIderived parameters of pulmonary function (ra and fD), and 
histologyderived parameters of lung structure (MLI and h) obtained from the shaminstilled (□), EPtreated 
(○), and CS and LPS (▲) mice after the 10 week experimental protocol. The Pearson’s r value and P value of 
statistical significance are noted in each plot.  
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